REHATRON™alpha - „Frequently asked questions“

1. Which contraindications does the non-invasive induction therapy (NIIT) wih REHATRON™alpha have?
2. Can REHATRON™alpha be applied at home?
3. Are there scientific studies on REHATRON™alpha?
4. Do health insurances bear the treatment costs with REHATRON™alpha?
5. How many therapy sessions are necessary?
6. In which countries has REHATRON™alpha been applied already?
7. Why is there no list of indications for the application with REHATRON™alpha?
8. Can a treatment with REHATRON™alpha be harmful?
9. Can the energy releases of REHATRON™alpha cause any harm like mobile phone frequencies?
10. Which side effects can a treatment with REHATRON™alpha involve?
11. Can REHATRON™alpha also be applied for animal diseases?
12. Are there comparable devices like REHATRON™alpha?

1. Which contraindications does the non-invasive induction therapy (NIIT) wih REHATRON™alpha have?

Contraindications are: pacemakers, pregnancy, defibrillators, implanted insulin-providing devices as well as circular, metallic implants.

2. Can REHATRON™alpha be applied at home?

Theoretically, yes. However, REHATRON™alpha should only be used in practices and clinics and executed by experts to guarantee the medical functioning and to avoid wrong application. Since private persons usually cannot afford the device, the question does not arise.

3. Are there scientific studies on REHATRON™alpha?

REHATRON™alpha had been tested thoroughly by doctors, engineers etc. before it entered the market. At the moment REHATRON™alpha is tested in randomized clinical studies in a renowned German clinic. Considering that such studies are time-consuming, the first results will appear at the earliest at the end of 2011. You can find an extract from one of the first studies in the area „clinical studies“.

4. Do health insurances bear the treatment costs with REHATRON™alpha?

The legal health insurances do not bear the treatment costs, only in certain cases. In case of private health insurances the treatment can be invoiced. Please discuss this with your doctor or medical practitioner.

5. How many therapy sessions are necessary?

This depends on the type and duration of a disease and on the individual organism. As a general rule two treatments per year in case of a chronic orthopedic disease, often only one treatment and sometimes 20 treatments or more.

6. In which countries has REHATRON™alpha been applied already?

Currently REHATRON™alpha is applied in Germany, Austria, Switzerland, Scandinavian countries, the Netherlands and France.

7. Why is there no list of indications for the application with REHATRON™alpha?

The Law on Advertising in the Health Care Service (in German: HWG) does not allow it. Only doctors and non-medical practitioners can access this information via the secure log-in area. In case of individual questions please ask the nearest user or contact us directly.

8. Can a treatment with REHATRON™alpha be harmful?

Not as long the contraindications are taken into account.

9. Can the energy releases of REHATRON™alpha cause any harm like mobile phone frequencies?

No. Only frequencies above 1 giga Hertz (= 1,000,000,000 Hertz) can make organic molecules response and lead to thermal effects and kinetic friction shiftings. REHATRON™alpha works with 220 kilo Hertz (= 220,000 Hertz), in 100 micro seconds. There is no danger for the human or animal organism.

10. Which side effects can a treatment with REHATRON™alpha involve?

The only „side effect“ is a sense of well-being in most patients. Other persons (approx. 10%) get tired after the treatment. In some cases it comes to an initial aggravation which subsides after some time.

11. Can REHATRON™alpha also be applied for animal diseases?

Yes. The veterinary doctors who use REHATRON™alpha have positive results in the treatment of horses, dogs and cats and other small animals. Please read the information in the area „press and news“.

12. Are there comparable devices like REHATRON™alpha?

Unfortunately, all successful developments are plagiarized or copied sooner or later, also REHATRON™alpha. The developers of REHATRON™alpha succeeded in 2008 in fighting a plagiarization in court (verdict OLG Stuttgart, Aktenzeichen: 2U86/07 – 11 O 30/07), but copies, partly in identical construction are circulating. Many people try to convey the impression that their therapies which carry a similar or even identical name are the original non-invasive induction therapy or even a further development. In fact, the terms „non-invasive induction therapy“ and „Rehatron“ are registered – only those devices carrying the label REHATRON™alpha work with the non-invasive induction therapy. You can find further information in the area „REHATRON™ history“.